D.E. Shaw & Co
EVHC.PR

D.E. Shaw & Co’s Envision Healthcare Corporation EVHC.PR Stock Holding History

D.E. Shaw & Co’s Portfolio EVHC.PR Stock Details EVHC.PR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-177,500
Closed -$20.2M – 3666
2017
Q1 		$20.2M Buy
177,500
+57,500
+48% +$7.15M 0.04% 572
2016
Q4 		$14.3M Buy
+120,000
New +$15.1M 0.02% 772

Other funds holding EVHC.PR

WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
ES
Equitec Specialists Chicago, Illinois $708K AUM 25.27% 1-Year Est. Return

D.E. Shaw & Co's EVHC.PR Position: Q2 2017 in Review

D.E. Shaw & Co sold out of Envision Healthcare Corporation (EVHC.PR) in Q2 2017, closing a stake of 177,500 shares — an estimated $20.2M sold.

D.E. Shaw & Co first reported a position in EVHC.PR in Q4 2016 and held it in 2 quarters. The position peaked at $20.2M in Q1 2017. 12 funds tracked by Wall St. Rank hold EVHC.PR as of Q2 2017.

  • D.E. Shaw & Co reported no remaining Envision Healthcare Corporation position as of Q2 2017 after selling out during the quarter.
  • D.E. Shaw & Co sold 177,500 Envision Healthcare Corporation shares in Q2 2017, an estimated $20.2M.
  • D.E. Shaw & Co first reported a position in Envision Healthcare Corporation in Q4 2016 and held it in 2 quarters.
  • D.E. Shaw & Co's Envision Healthcare Corporation position peaked at $20.2M in Q1 2017.
  • 12 funds tracked by Wall St. Rank held Envision Healthcare Corporation as of Q2 2017.

Based on D.E. Shaw & Co's 13F filing for Q2 2017, filed 14 Aug 2017.